Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05029596 · ClinicalTrials.gov registry record · Early Phase 1
Heparin Versus Normal Saline in Peripherally Inserted Central Catheter Lines
A Early Phase 1 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 142
- Enrollment target
NCT05029596 is a Early Phase 1 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 142 participants.
The verdict
NCT05029596, a Early Phase 1 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 142 participants
- Enrollment target
Study Summary
The study team will be performing a study comparing the use of Heparin Flushes vs. Normal Saline Flushes in making sure central lines stay open. The participants will be placed in a group to receive the University of Texas Southwestern Medical Center (UTSW) Standard of Care (control group) for maintaining central lines, or a group to receive Normal Saline Flushes only (experimental group) to keep their central line open. The participants electronic medical record will be reviewed by study team members for the inclusion/exclusion criteria, the participants central line will be assessed by an 11 Blue BMT nurse every 12 hours, and they may be asked questions regarding their medical history during their stay on 11 Blue BMT. If a participant is discharged or transferred off of the 11 Blue BMT unit, they will no longer be included in the study and their central line maintenance will return to the UTSW Standard of Care. Participants in this study may be at risk for central line occlusion (a blood clot) which could require intervention to regain the free flow of fluids and use of the central line. The study team predicts there will be no increase in the rate of line occlusion when using Normal Saline Flushes only to maintain the free flow of fluids through participants central line. The study team also hopes the results of this study will help to improve patient outcomes by decreasing risk of infection, heparin associated complications, and costs.
Interventions
- DRUG Normal Saline Group
- DRUG Heparin Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2023-03-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05029596
The ClinicalTrials.gov registry entry for NCT05029596 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline Group is the first listed.
NCT05029596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05029596 about?
NCT05029596 is a clinical study titled "Heparin Versus Normal Saline in Peripherally Inserted Central Catheter Lines". The study team will be performing a study comparing the use of Heparin Flushes vs. Normal Saline Flushes in making sure central lines stay open. The participants will be placed in a group to receive the University of Texas Southwestern Medical Center (UTSW) Standard of Care (control group) for maint...
What is the current status of trial NCT05029596?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 142 participants. The study started on 2020-02-12. Estimated completion is 2023-03-30.
What interventions are being tested in trial NCT05029596?
The interventions under investigation include: Normal Saline Group (DRUG), Heparin Group (DRUG).
Who is sponsoring clinical trial NCT05029596?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.